185 related articles for article (PubMed ID: 30648121)
21. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.
Ferris RL; Hunt JL; Ferrone S
Immunol Res; 2005; 33(2):113-33. PubMed ID: 16234579
[TBL] [Abstract][Full Text] [Related]
22. In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
Hoves S; Aigner M; Pfeiffer C; Laumer M; Obermann EC; Mackensen A
Leukemia; 2009 May; 23(5):877-85. PubMed ID: 19148137
[TBL] [Abstract][Full Text] [Related]
23. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
Vigna JL; Smith KD; Lutz CT
J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
[TBL] [Abstract][Full Text] [Related]
24. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
Chang CC; Campoli M; Restifo NP; Wang X; Ferrone S
J Immunol; 2005 Feb; 174(3):1462-71. PubMed ID: 15661905
[TBL] [Abstract][Full Text] [Related]
25. Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
Paschen A; Méndez RM; Jimenez P; Sucker A; Ruiz-Cabello F; Song M; Garrido F; Schadendorf D
Int J Cancer; 2003 Mar; 103(6):759-67. PubMed ID: 12516095
[TBL] [Abstract][Full Text] [Related]
26. Defective major histocompatibility complex class I expression in a sarcomatoid renal cell carcinoma cell line.
Jakobsen MK; Restifo NP; Cohen PA; Marincola FM; Cheshire LB; Linehan WM; Rosenberg SA; Alexander RB
J Immunother Emphasis Tumor Immunol; 1995 May; 17(4):222-8. PubMed ID: 7582258
[TBL] [Abstract][Full Text] [Related]
27. Defective HLA class I antigen processing machinery in cancer.
Cai L; Michelakos T; Yamada T; Fan S; Wang X; Schwab JH; Ferrone CR; Ferrone S
Cancer Immunol Immunother; 2018 Jun; 67(6):999-1009. PubMed ID: 29487978
[TBL] [Abstract][Full Text] [Related]
28. Analysis of HLA-E expression in human tumors.
Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
[TBL] [Abstract][Full Text] [Related]
29. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
30. Transport and expression of class I MHC glycoproteins in an antigen-processing mutant cell line.
Click EM; Anderson KS; Androlewicz MJ; Wei ML; Cresswell P
Cold Spring Harb Symp Quant Biol; 1992; 57():571-7. PubMed ID: 1339695
[No Abstract] [Full Text] [Related]
31. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.
D'Urso CM; Wang ZG; Cao Y; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jan; 87(1):284-92. PubMed ID: 1898655
[TBL] [Abstract][Full Text] [Related]
32. Expression of HLA class-I antigens on renal cell carcinoma and non-transformed renal tissue.
Buszello H; Ackermann R
Eur Urol; 1992; 21(1):70-4. PubMed ID: 1606987
[TBL] [Abstract][Full Text] [Related]
33. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
[TBL] [Abstract][Full Text] [Related]
34. HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status.
Cao J; Brouwer NJ; Jordanova ES; Marinkovic M; van Duinen SG; de Waard NE; Ksander BR; Mulder A; Claas FHJ; Heemskerk MHM; Jager MJ
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1005-1015. PubMed ID: 29450544
[TBL] [Abstract][Full Text] [Related]
35. Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells.
Sabbatino F; Schwab JH; Ferrone S; Ferrone CR
Clin Transpl; 2013; ():453-63. PubMed ID: 25095541
[TBL] [Abstract][Full Text] [Related]
36. Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon.
Imanishi T; Kamigaki T; Nakamura T; Hayashi S; Yasuda T; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Kobe J Med Sci; 2006; 52(3-4):85-95. PubMed ID: 16855371
[TBL] [Abstract][Full Text] [Related]
37. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus.
Barnes PD; Grundy JE
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2395-403. PubMed ID: 1328494
[TBL] [Abstract][Full Text] [Related]
39. The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes.
Lagaudrière-Gesbert C; Lebel-Binay S; Wiertz E; Ploegh HL; Fradelizi D; Conjeaud H
J Immunol; 1997 Mar; 158(6):2790-7. PubMed ID: 9058814
[TBL] [Abstract][Full Text] [Related]
40. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
